Clinical Trial Update: Multi-vitamins, HAART and HIV/AIDS in Uganda [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating multivitamin supplementation in combination with HAART for HIV/AIDS in Uganda has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Aids

Drugs mentioned

• HAART (Highly Active Antiretroviral Therapy)
• Multivitamins (multivitamin)

Snippet

Sponsor: Harvard School of Public Health (HSPH) | Conditions: HIV/AIDS | Phase 3 | Status: COMPLETED